Association Between Disease-Modifying Therapies Prescribed to Persons with Multiple Sclerosis and Cancer: a WHO Pharmacovigilance Database Analysis
Charles Dolladille, Basile Chrétien, Laure Peyro‐Saint‐Paul, Joachim Alexandre, Olivier Dejardin, Sophie Fédrizzi, Gilles Defer
Topics & Concepts
MedicineFingolimodNatalizumabTeriflunomideInternal medicineGlatiramer acetateMultiple sclerosisOncologyPharmacovigilanceCancerDatabaseAdverse effectDiseaseImmunologyComputer sciencePolyomavirus and related diseasesMultiple Sclerosis Research StudiesCancer Immunotherapy and Biomarkers